A doctor shared the case of a woman who walked into his clinic with a haemoglobin level of 1.9 g/dL (dangerously low). His ...

Researchers conducted a retrospective observational study using registry data from Italy (January 2009 to April 2021) to examine the prevalence and characteristics of anaemia in children younger than ...

daily multivitamin does not reduce the risks of cvd in men Iron therapy and erythropoiesis-stimulating agents are not always effective for anemia in patients with CKD. Nutritional interventions may be ...

In a small study, approximately a third of kidney transplant recipients had anemia and half had persistent secondary hyperparathyroidism. Despite the favorable effects of kidney transplantation on ...

A 50-year-old woman was admitted to the hospital because of vaginal bleeding and anemia. She had a history of fibroids and 1 ...

Background: A 56-year-old male with a history of excess alcohol consumption for over 10 years and type 2 diabetes mellitus (diagnosed 14 years previously) presented to the accident and emergency ...

dementia Additional studies are needed to determine whether anemia itself is a risk factor for dementia in the CKD population. Anemia in patients with chronic kidney disease (CKD) portends an ...

Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary angiotensinogen (AGT). “What we’re most excited about is that urinary ...

In the months since the FDA's high-profile rejection for oral anemia drug roxadustat, AstraZeneca and FibroGen have been working to chart a potential path forward for the med in chronic kidney disease ...

After two prior FDA rejections for oral anemia drugs in the hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) drug class, GSK’s daprodustat, branded as Jesduvroq, has won a class-first ...